Remed Co.,Ltd. (KOSDAQ:302550)

Market Cap	97.82B +4.7%
Revenue (ttm)	24.50B -4.1%
Net Income	526.20M -92.7%
EPS	9.00 -96.0%
Shares Out	30.91M
PE Ratio	185.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,906
Average Volume	115,485
Open	3,175.00
Previous Close	3,180.00
Day's Range	3,105.00 - 3,210.00
52-Week Range	2,640.00 - 4,595.00
Beta	0.76
RSI	54.72
Earnings Date	May 12, 2026

About Remed

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In a...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 92
• Stock Exchange: KOSDAQ
• Ticker Symbol: 302550

Financial Performance

In 2025, Remed's revenue was 24.50 billion, a decrease of -4.11% compared to the previous year's 25.55 billion. Earnings were 526.20 million, a decrease of -92.66%.